Nanoparticle-Based Drug Delivery for Vascular Applications
2024
Nanoparticle-Based Drug Delivery for Vascular Applications
publication
Evidence: moderate
Author Information
Author(s): Naskar Atanu, Kilari Sreenivasulu, Baranwal Gaurav, Kane Jamie, Misra Sanjay
Primary Institution: Mayo Clinic, Rochester, MN, USA
Conclusion
Nanoparticle-based drug delivery systems show great potential for improving targeted therapies in vascular applications.
Supporting Evidence
- Nanoparticles can cross cell membranes and deliver drugs directly to target sites.
- Different types of nanoparticles have unique properties that make them suitable for various drug delivery applications.
- Nanoparticle behavior in blood vessels is influenced by their size, shape, and surface characteristics.
Takeaway
Scientists are using tiny particles to help deliver medicine directly to blood vessels, which can make treatments work better.
Methodology
This review discusses various types of nanoparticles and their behaviors in blood vessels, as well as their applications in drug delivery.
Limitations
The review highlights the need for further investigation into the toxicity and biodegradability of certain nanoparticles.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website